首页> 中文期刊>吉林医学 >肾上腺素联合异丙肾上腺素雾化治疗喘息型支气管炎的疗效

肾上腺素联合异丙肾上腺素雾化治疗喘息型支气管炎的疗效

     

摘要

Objective To observe the clinical curative effect of atomization inhalation of epinephrine and isoproterenol in treating asthmat-ic bronchitis. Method 112 patients with asthmatic bronchitis were randomly divided into observation group and control group,56 cases in each group. The patients in the control group were treated with conventional treatment,and on the basis of this,the patients in the observation group were treated with atomization inhalation of epinephrine and isoproterenol for 3 ~5 days. After the treatment,the clinical effects were e-valuated according to the disappearance time of clinical index such as cough,asthma remission and pulmonary wheezing. Results In the obser-vation group,the disappearance time of cough,asthma remission and pulmonary wheezing were significantly shorter than those in the control group(P <0. 05),The total effective rates in the observation group was 96. 43% ,which was significantly higher than that in the control group (78. 57% )(P < 0. 05). Conclusion The therapeutic effect of atomization inhalation of epinephrine and isoproterenol in treating asthmatic bronchitis is significant.%目的:观察肾上腺素联合异丙肾上腺素雾化治疗喘息型支气管炎的临床疗效。方法:将112例喘息型支气管炎患者随机分为观察组和对照组,每组各56例,对照组采用常规治疗方案,观察组在此基础上加用肾上腺素联合异丙肾上腺素雾化治疗,连续治疗3~5 d。治疗期间,观察两组患者咳嗽、气喘缓解及肺部哮鸣音消失情况,并评定治疗效果。结果:观察组患者咳嗽、肺部哮鸣音、喘息等临床观察指标消失时间均显著短于对照组(P <0.05),且住院时间显著短于对照组(P <0.05),观察组临床总有效率为96.43%,显著优于对照组的78.57%(P <0.05)。结论:肾上腺素联合异丙肾上腺素雾化治疗喘息型支气管炎的临床疗效显著。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号